John T. Powers

This study shows that ultra-high dose arachidonic acid promotes neuroblastoma growth in mice, while docosahexaenoic acid suppresses tumor progression and survival.

This paper shows that ultra-high dose omega-3 fatty acids block tumor formation in a neuroblastoma model, while omega-6 fatty acids promote it.

This study shows that full-length MYCN mRNA with noncoding elements drives oncogenesis more effectively than MYCN protein alone, revealing new insights into cancer mechanisms.

The paper identifies sex-biased outcomes in neuroblastoma, showing female patients with MYCN non-amplified high-risk disease have worse survival than males, linked to H19/DLK1 expression and chromosome 11q retention.